Bios in the News
Case Studies
Helpful Articles & videos
Our Highly regarded White Paper “Strategies and Innovations to Speed Up Drug Development into today’s dynamic market post COVID-19 )
1. Rare diseases: understanding the patient journey (manufacturingchemist.com)
2. Diversity in Clinical Trials: Going Beyond Why to How – ACRP (acrpnet.org)
3. Sertkaya, A; Wong, H. H.; Jessup, A; Beleche, T (2016). “Key cost drivers of pharmaceutical clinical trials in the United States.” Clinical Trials. 13 (2): 117–26. doi:10.1177/1740774515625964. PMID 26908540. S2CID 24308679.
4. JP Morgan 2024 Unveils Biotech’s Next Horizon: A Glimpse into the Future of Investments
5. Accelerating Success: How Biotech Innovations Drive Investment and Partnerships
6. Maximizing Pipeline Potential: Strategic Clinical Development in the Modern Era
7. Navigating the Biotech Funding Landscape: Insights for Success
8. Exciting News for Biotech Companies in Phase 2 or 3 Clinical Development
1. Rare diseases: understanding the patient journey (manufacturingchemist.com)
2. Diversity in Clinical Trials: Going Beyond Why to How – ACRP (acrpnet.org)
3. Sertkaya, A; Wong, H. H.; Jessup, A; Beleche, T (2016). “Key cost drivers of pharmaceutical clinical trials in the United States.” Clinical Trials. 13 (2): 117–26. doi:10.1177/1740774515625964. PMID 26908540. S2CID 24308679.
4. JP Morgan 2024 Unveils Biotech’s Next Horizon: A Glimpse into the Future of Investments
5. Accelerating Success: How Biotech Innovations Drive Investment and Partnerships
6. Maximizing Pipeline Potential: Strategic Clinical Development in the Modern Era
7. Navigating the Biotech Funding Landscape: Insights for Success
8. Exciting News for Biotech Companies in Phase 2 or 3 Clinical Development
Board Identification of Diverse Members
On Demand Key Talent
The Bios Health Group Story
Strategic Guidance to Accelerate Drug Development
Innovative Solutions to increase Clinical Trial Diversity
CRO Selection and Management
Contact Us